Umeå University's logo

umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Mutant SOD1 aggregates formed in vitro and in cultured cells are polymorphic and differ from those arising in the CNS
Umeå University, Faculty of Medicine, Department of Clinical Sciences, Neurosciences.ORCID iD: 0000-0002-7757-2344
Department of Biochemistry and Biophysics, Arrhenius Laboratories of Natural Sciences, Stockholm University, Stockholm, Sweden.
Umeå University, Faculty of Medicine, Department of Clinical Sciences, Neurosciences. Umeå University, Faculty of Medicine, Department of Medical Biosciences, Clinical chemistry.ORCID iD: 0000-0002-3787-7629
Umeå University, Faculty of Medicine, Department of Medical Biosciences, Clinical chemistry.
Show others and affiliations
2023 (English)In: Journal of Neurochemistry, ISSN 0022-3042, E-ISSN 1471-4159, Vol. 164, no 1, p. 77-93Article in journal (Refereed) Published
Abstract [en]

Mutations in the human Superoxide dismutase 1 (hSOD1) gene are well-established cause of the motor neuron disease ALS. Patients and transgenic (Tg) ALS model mice carrying mutant variants develop hSOD1 aggregates in the CNS. We have identified two hSOD1 aggregate strains, which both transmit spreading template-directed aggregation and premature fatal paralysis when inoculated into adult transgenic mice. This prion-like spread of aggregation could be a primary disease mechanism in SOD1-induced ALS. Human SOD1 aggregation has been studied extensively both in cultured cells and under various conditions in vitro. To determine how the structure of aggregates formed in these model systems related to disease-associated aggregates in the CNS, we used a binary epitope-mapping assay to examine aggregates of hSOD1 variants G93A, G85R, A4V, D90A, and G127X formed in vitro, in four different cell lines and in the CNS of Tg mice. We found considerable variability between replicate sets of in vitro-generated aggregates. In contrast, there was a high similarity between replicates of a given hSOD1 mutant in a given cell line, but pronounced variations between different hSOD1 mutants and different cell lines in both structures and amounts of aggregates formed. The aggregates formed in vitro or in cultured cells did not replicate the aggregate strains that arise in the CNS. Our findings suggest that the distinct aggregate morphologies in the CNS could result from a micro-environment with stringent quality control combined with second-order selection by spreading ability. Explorations of pathogenesis and development of therapeutics should be conducted in models that replicate aggregate structures forming in the CNS. (Figure presented.)

Place, publisher, year, edition, pages
John Wiley & Sons, 2023. Vol. 164, no 1, p. 77-93
Keywords [en]
aggregate structure, ALS, amyotrophic lateral sclerosis, neurodegenerative disease, superoxide dismutase 1, protein misfolding, protein aggregation, aggregate strains, aggregate conformation
National Category
Neurosciences
Identifiers
URN: urn:nbn:se:umu:diva-201477DOI: 10.1111/jnc.15718ISI: 000890056900001PubMedID: 36326589Scopus ID: 2-s2.0-85142644226OAI: oai:DiVA.org:umu-201477DiVA, id: diva2:1716454
Funder
The Swedish Brain Foundation, 2013-0279The Swedish Brain Foundation, 2016-0303The Swedish Brain Foundation, 2018-0310The Swedish Brain Foundation, 2020-0353The Kempe FoundationsKnut and Alice Wallenberg Foundation, 2012.0091Knut and Alice Wallenberg Foundation, 2014.0305Knut and Alice Wallenberg Foundation, 2020.0232Konung Gustaf V:s och Drottning Victorias FrimurarestiftelseSwedish Association of Persons with Neurological DisabilitiesTorsten Söderbergs stiftelseUmeå University, 2.1.12-1605-14Umeå University, 223-1881-13Umeå University, 223-2808-12Region Västerbotten, 56103- 7002829Swedish Research Council, 2017-03100Swedish Research Council, 2012-3167Available from: 2022-12-06 Created: 2022-12-06 Last updated: 2023-01-11Bibliographically approved

Open Access in DiVA

fulltext(12365 kB)245 downloads
File information
File name FULLTEXT02.pdfFile size 12365 kBChecksum SHA-512
b2e86ee13713a3d64007c859420d9fe33dbb75f82c2014f728f92399bc89912f80a405d5e5bd03283749186738a3d1c9da786e051bc8c0048669cd1d1e138785
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Nordström, UlrikaEkhtiari Bidhendi, ElahehZetterström, PerAndersen, Peter M.Marklund, Stefan L.

Search in DiVA

By author/editor
Nordström, UlrikaEkhtiari Bidhendi, ElahehZetterström, PerAndersen, Peter M.Marklund, Stefan L.
By organisation
NeurosciencesClinical chemistry
In the same journal
Journal of Neurochemistry
Neurosciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 269 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 513 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf